An increasing number of studies has highlighted the important role of the microbiome in human health and disease. However, information on the composition of the microbiome in different parts of the body across countries, ages, sexes, and in relation to human health and disease is still limited. More importantly, though thousands of peer-reviewed papers have been published, very few open access databases are available. With the featured MGI DNBSEQ™ sequencing technology, the MMHP aims to sequence and analyze one million microbiome samples in the coming 3-5 years, focusing on feces and saliva (other body sites for which large number of samples can be obtained will be accepted), and make the first comprehensive map of the human microbiome publicly available.
Download the Flyer
Director of Center for Translational Microbiome Research at Karolina Institute, Sweden
Stanislav Dusko Ehrlich
Director of MetaGenopolis at INRA, France
Director of Shanghai national Clinical Research Center for Metabolic Diseases, China
The project benefit the efficiency and the precision of MGI's technology. MGI has developed its sequencing proprietary technologies DNBSEQ ™. This patented technology uses rolling circle amplification and patterned array technology to deliver more accurate sequencing data with decreased duplicates and free of index hopping, error accumulation and amplification bias of PCR technology.
Interested to join the MMHP? Please, fill the form, our team will contact you